English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cervical cancer is the fourth most common cancer among women. In 2012, there were an estimated 528,000 new cases and 266,000 deaths from cervical cancer worldwide accounting for 7.5% of all female cancer deaths [4]. Treatment for cervical cancer is complex and can include surgery, chemotherapy, and radiation therapy. The associated costs of cervical cancer are extreme, not just in the cost of treatment but also in work rate. In the U.S., alone, the cost of cancer of the cervix was reported as follows (in USD): initial: 45,174; continuing:1,425; last year of life (cancer death): 78,553; (other causes): 7,949 [5].

sm preventive medicine and public health

A Global Health Preventive Medicine Overture: Lycopene as an Anticancer and Carcinopreventive Agent in the Deterrence of Cervical Cancer Liking Lycopene